<SEC-DOCUMENT>0001140361-24-044363.txt : 20241028
<SEC-HEADER>0001140361-24-044363.hdr.sgml : 20241028
<ACCEPTANCE-DATETIME>20241028082247
ACCESSION NUMBER:		0001140361-24-044363
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241024
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241028
DATE AS OF CHANGE:		20241028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Grace Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001444192
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35776
		FILM NUMBER:		241398480

	BUSINESS ADDRESS:	
		STREET 1:		103 CARNEGIE CENTER
		STREET 2:		SUITE 300
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		609-322-1602

	MAIL ADDRESS:	
		STREET 1:		103 CARNEGIE CENTER
		STREET 2:		SUITE 300
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Acasti Pharma Inc.
		DATE OF NAME CHANGE:	20080828
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20037633_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:grce="http://acasti.com/20241024" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions. Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e54af903f66e49ddabd66693de17fa37" contextRef="c20241024to20241024" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="Fact_c71d4793dc7342339fd3fa30c2fb687b" contextRef="c20241024to20241024" format="ixt:date-month-day">03-31</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_06be0aa4f82b42f79a981e8decd9069e" contextRef="c20241024to20241024">Grace Therapeutics, Inc.</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_443d33fc2aec4028b1492a535ee27a37" contextRef="c20241024to20241024">0001444192</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="grce-20241024.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20241024to20241024"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001444192</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-24</xbrli:startDate><xbrli:endDate>2024-10-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
  <div>
    <div style="font-family: 'Times New Roman'; font-size: 14pt;">
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">UNITED STATES</div>

    </div>

    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_dc309d8c63e74a46a1d2814207b8941e" contextRef="c20241024to20241024">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d)</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">of the Securities Exchange Act of 1934</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_fd16dd88e4c54d3795d60d74abeb203f" contextRef="c20241024to20241024" format="ixt:date-monthname-day-year-en">October 24, 2024</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_06be0aa4f82b42f79a981e8decd9069e">GRACE THERAPEUTICS, INC.</span><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact Name of Registrant as Specified in its Charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_cc76f6e46ff943ffaa0bef69a4184ff8" contextRef="c20241024to20241024" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_c549979620d840b88eb207f6e345ed6e" contextRef="c20241024to20241024">001-35776</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 33.29%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_cfb2405198bb44ddb0f8850a92b1ecb1" contextRef="c20241024to20241024">98-1359336</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(State or Other Jurisdiction of Incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Commission File Number)</div>
          </td>

    <td style="width: 33.29%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_4732f0dfbbf840dfb1a06e732e0e966e" contextRef="c20241024to20241024">103 Carnegie Center</ix:nonNumeric><br/>
              </div>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_484b7671eb834469b07b796f4a575e3d" contextRef="c20241024to20241024">Suite 300</ix:nonNumeric><br/>
            </div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_42656537c6b44218970fa4c3f4ad67c1" contextRef="c20241024to20241024">Princeton</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_12ee8f7f0dc14be38430a63fa0eabde1" contextRef="c20241024to20241024" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric></div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_457b797bf9664a8e84c25f113f78d674" contextRef="c20241024to20241024">08540</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Address of Principal Executive Offices)</div>
          </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: center;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_56ca8b74b911418e883ecf163a2a15b4" contextRef="c20241024to20241024">609</ix:nonNumeric>)
      <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_9d242bab3e8548bba5052217e93a7431" contextRef="c20241024to20241024">322-1602</ix:nonNumeric></div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Acasti Pharma Inc.</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_0f6fa2e3b9f14d9fa8e6b84430fa0554" contextRef="c20241024to20241024" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_f1b0c3cb67744eed91c5ce32fd05b238" contextRef="c20241024to20241024" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_5076829062264080b2d4c968f4a23f4d" contextRef="c20241024to20241024" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_c8b9822994054aaf803327c7ff2de257" contextRef="c20241024to20241024" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
            <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; text-indent: -27pt; margin-left: 27pt; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 39%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div>
              <div style="text-align: center; font-weight: bold;">Title of each class</div>
            </div>
          </td>

    <td style="width: 1.05%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div>
              <div style="text-align: center; font-weight: bold;">Trading Symbol(s)</div>
            </div>
          </td>

    <td style="width: 1.05%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 39%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div>
              <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 39%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_6dbff5feeb024a62a0dd280dcf623196" contextRef="c20241024to20241024">Common Stock, par value $0.0001 per share</ix:nonNumeric><br/>
          </td>

    <td style="width: 1.05%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_4f604bbfcb1d41f69e00b3efc3178e66" contextRef="c20241024to20241024">GRCE</ix:nonNumeric><br/>
          </td>

    <td style="width: 1.05%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 39%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_742438339723401c9acdd617e8e3451a" contextRef="c20241024to20241024">NASDAQ</ix:nonNumeric><br/>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2
      of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_fe592cdac61f4a13aa3bba5b18c9f91a" contextRef="c20241024to20241024" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

    <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.03.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On October 24, 2024, Grace Therapeutics, Inc. (the &#8220;Company&#8221;) filed a certificate of amendment (the &#8220;Certificate of Amendment&#8221;) to its Certificate of
      Incorporation with the Secretary of State of the State of Delaware solely to change the Company&#8217;s name from &#8220;Acasti Pharma Inc.&#8221; to &#8220;Grace Therapeutics, Inc.&#8221; The name change became effective on October 28, 2024. A copy of the Certificate of
      Amendment is attached as Exhibit 3.1 hereto and incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the name change, the Company&#8217;s Board of Directors amended the Company&#8217;s Bylaws (the &#8220;Bylaws&#8221;) to reflect the Company&#8217;s name change,
      also effective October 28, 2024. No other changes were made to the Bylaws. A copy of the Bylaws reflecting this amendment is attached as Exhibit 3.2 hereto and incorporated herein by reference.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s common stock previously traded on the Nasdaq Stock Market under the ticker symbol &#8220;ACST&#8221; and, effective as of October 28, 2024, is trading
      on the Nasdaq Stock Market under the new ticker symbol &#8220;GRCE&#8221;.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The name change does not affect the rights of the Company&#8217;s security holders, and the CUSIP number for the Company&#8217;s common stock will continue to be
      00439U104.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 72pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d) Exhibits</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0);">Exhibit</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 91.59%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0);">Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;"><a href="ef20037633_ex3-1.htm">3.1</a></div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 91.59%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Certificate of Amendment to the Certificate of Incorporation of Grace Therapeutics, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;"><a href="ef20037633_ex3-2.htm">3.2</a></div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 91.59%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left;">Bylaws of Grace Therapeutics, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0);">104</div>
          </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 91.59%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0);">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 55%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" rowspan="1" colspan="2">
            <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">GRACE THERAPEUTICS, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 55%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 55%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">October </span><span style="font-family: 'Times New Roman'; font-size: 10pt;">28<span style="color: rgb(0, 0, 0);">, 2024</span></span></div>
          </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify; color: rgb(0, 0, 0);">By:</div>
          </td>

    <td style="width: 40%; vertical-align: top;">
            <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"><span style="text-decoration: underline;">/s/ </span></span><span style="font-size: 10pt; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Prashant




                  Kohli</span></span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 55%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Name:</div>
          </td>

    <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Prashant Kohli</div>
          </td>

  </tr>

  <tr>

    <td style="width: 55%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Title:</div>
          </td>

    <td style="width: 40%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: justify;">Chief Executive Officer</div>
          </td>

  </tr>


</table>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
    </div>

    <div style="font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ef20037633_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions. Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="font-weight: bold; text-align: right;">Exhibit 3.1<br>
    </div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTIFICATE OF AMENDMENT</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TO THE</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTIFICATE OF INCORPORATION</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF</div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ACASTI PHARMA INC.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Acasti Pharma Inc., a corporation organized and existing under the laws of the State of Delaware (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Corporation</u></font>&#8221;), hereby certifies as follows:</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">FIRST:</font>&#160; That the first Article of the
      Certificate of Incorporation of the Corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Certificate of Incorporation</u></font>&#8221;) is hereby amended and restated in its entirety as follows:</div>
    <div>&#160;</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE I</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The name of the corporation (the &#8220;Corporation&#8221;) is Grace Therapeutics, Inc.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">SECOND:</font>&#160; That this Certificate of Amendment
      to the Certificate of Incorporation was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">THIRD:</font>&#160; That, except as amended hereby, the
      provisions of the Certificate of Incorporation shall remain in full force and effect.</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">FOURTH:&#160; </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">That this Certificate of Amendment to the Certificate of Incorporation shall be effective as of </font>October 28<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">,
        2024.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Remainder of Page Intentionally Blank</font>]</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">IN WITNESS WHEREOF</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, the Corporation has caused this Certificate of Amendment to the Certificate of Incorporation to be signed by an authorized officer of the Corporation this 24th day of </font>October<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">, 2024.</font></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z55078171e8344690ae0b499f19a6c837">

        <tr>
          <td style="width: 49.98%; vertical-align: top;"><br>
          </td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ACASTI PHARMA INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;"><br>
          </td>
          <td style="vertical-align: top;" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:<u></u></div>
          </td>
          <td style="width: 45%; vertical-align: top;"> <u><font style="font-size: 10pt; font-family: 'Times New Roman';">/s/ Prashant Kohli</font></u></td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name:<br>
            </div>
          </td>
          <td style="width: 45%; vertical-align: top;">Prashant Kohli</td>
        </tr>
        <tr>
          <td style="width: 49.98%; vertical-align: top;"><br>
          </td>
          <td style="width: 5%; vertical-align: top;">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Title:<br>
            </div>
          </td>
          <td style="width: 45%; vertical-align: top;">Chief Executive Officer</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>ef20037633_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions. Inc.
         Document created using Broadridge PROfile 24.9.1.5252
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--><font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 3.2</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BYLAWS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">GRACE THERAPEUTICS, INC. </div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE I.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OFFICES</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 1.01&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Registered Office</u></font>. The registered office and registered agent of Grace
      Therapeutics, Inc. (the &#8220;Corporation&#8221;) in the State of Delaware shall be as set forth in the Corporation&#8217;s certificate of incorporation as then in effect (as the same may be amended and/or restated from time to time, the &#8220;Certificate of
      Incorporation&#8221;).</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 1.02&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Other Offices</u></font>. The Corporation may also have offices in such other
      places in the United States or elsewhere (and may change the Corporation&#8217;s registered agent) as the Board of Directors may, from time to time, determine or as the business of the Corporation may require as determined by any officer of the
      Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE II.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MEETINGS OF STOCKHOLDERS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.01&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Annual Meetings</u></font>. Annual meetings of stockholders may be held at such
      place, if any, either within or without the State of Delaware, and at such time and date as the Board of Directors shall determine and state in the notice of meeting. The Board of Directors may, in its sole discretion, determine that annual meetings
      of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as described in Section 2.12 in accordance with the General Corporation Law of the State of Delaware, as from time to time amended (the
      &#8220;DGCL&#8221;). At the annual meeting, directors shall be elected and other proper business properly brought before the meeting in accordance with Section 2.03 of these Bylaws of the Corporation (as amended and/or restated from time to time, the &#8220;Bylaws&#8221;)
      may be transacted. The Board of Directors may postpone, reschedule or cancel any annual meeting of stockholders previously scheduled by the Board of Directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.02&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Special Meetings</u></font>. Except as otherwise required by law and subject to the
      rights of the holders of any series of Preferred Stock, special meetings of the stockholders of the Corporation for any purpose or purposes may be called as provided in the Certificate of Incorporation. Only those matters set forth in the notice of
      the special meeting may be considered or acted upon at a special meeting of stockholders of the Corporation. A special meeting may be held at such place, if any, either within or without the State of Delaware, and at such time and date as the Board
      of Directors shall determine and state in the notice of meeting. The Board of Directors may, in its sole discretion, determine that special meetings of stockholders shall not be held at any place, but may instead be held solely by means of remote
      communication as described in Section 2.12 in accordance with the DGCL. The Board of Directors may postpone, reschedule or cancel any special meeting of stockholders previously scheduled by the Board of Directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.03&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Notice of Stockholder Business and Nominations</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; font-size: 10pt; text-indent: 72pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Annual Meetings of
            Stockholders</u></font>.&#160; (i) Nominations of persons for election to the Board of Directors and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (A) pursuant to the
        Corporation&#8217;s notice of meeting (or any supplement thereto), (B) by or at the direction of the Board of Directors or authorized committee thereof or (C) by any stockholder of the Corporation who was a stockholder of record of the Corporation at the
        time the notice provided for in this Section 2.03 is delivered to the Secretary of the Corporation and at the time of the meeting, who is entitled to vote at the meeting and who complies with the notice procedures set forth in this Section 2.03.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160; &#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">For any nominations or other business
          to be properly brought before an annual meeting by a stockholder pursuant to Section 2.03(a)(i)(C), the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation and any such proposed business (other than
          the nominations of persons for election to the Board of Directors) must constitute a proper matter for stockholder action.&#160; To be timely, a stockholder&#8217;s notice shall be delivered to the Secretary at the principal executive offices of the
          Corporation not later than the close of business on the ninetieth (90th) day, nor earlier than the one hundred twentieth (120th) day, prior to the first anniversary of the preceding year&#8217;s annual meeting (which preceding year&#8217;s annual meeting
          shall, for purposes of the Corporation&#8217;s first annual meeting after the has domesticated to the State of Delaware, be deemed to have occurred on September 30, 2024); provided, however, that in the event that the date of the annual meeting is more
          than thirty (30) days before or more than seventy (70) days after such anniversary date, notice by the stockholder must be so delivered not earlier than the one hundred twentieth (120th) day prior to such annual meeting and not later than the
          close of business on the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made by the Corporation.&#160; In no event shall the
          public announcement of an adjournment, recess or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of a stockholder&#8217;s notice as described above.&#160; The number of nominees a Proposing Person (as
          defined below) may nominate for election at the annual meeting shall not exceed the number of directors to be elected at such annual meeting.&#160; Such stockholder&#8217;s notice shall set forth:</font></font></div>
    <div style="text-align: justify; text-indent: 63pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
        </font></font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(A) as to each person whom the Proposing Person proposes to nominate for election as a director (1) all information relating to
      such person that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case pursuant to and in accordance with Section 14(a) of the Securities Exchange Act of 1934,
      as amended, and the rules and regulations promulgated thereunder (as so amended and inclusive of such rules and regulations, the &#8220;Exchange Act&#8221;), (2) all information required to be provided by a Proposing Person in Section 2.03(a)(ii)(C) and Section
      2.03(a)(ii)(E), (3) such person&#8217;s written consent to being named in the Corporation&#8217;s proxy statement and accompanying proxy card relating to the Corporation&#8217;s next meeting of stockholders at which directors are to be elected and to serving as a
      director for a full term if elected, (4) a description of any direct or indirect material interest in any material contract or agreement between or among any Proposing Person, on the one hand, and each candidate for nomination or his or her
      respective associates or any other participants in such solicitation, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Proposing Person were the
      &#8220;registrant&#8221; for purposes of such rule and the candidate for nomination were a director or executive officer of such registrant, (5) a questionnaire completed and signed by such person (in the form to be provided by the Secretary upon written request
      of any stockholder of record within ten (10) days of such request) with respect to the background, qualification and stock ownership of such proposed nominee and (6) a written representation and agreement completed and signed by such person (in the
      form to be provided by the Secretary upon written request of any stockholder of record within ten (10) days of such request) that such proposed nominee (x) is not and will not become a party to any agreement, arrangement or understanding with, and
      has not given any commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question that has not been disclosed to the Corporation or that could
      limit or interfere with such proposed nominee&#8217;s fiduciary duties under applicable law, (y) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any
      direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has not been disclosed to the Corporation, and (z) would be in compliance, if elected as a director of the Corporation, and will
      comply with, all applicable disclosed corporate governance, code of conduct and ethics, conflict of interest, confidentiality, corporate opportunities, trading and any other policies and guidelines of the Corporation applicable to directors and in
      effect during such person&#8217;s term in office as a director (and, if requested by any candidate for nomination, the Secretary shall provide to such candidate for nomination all such policies and guidelines then in effect);</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(B) as to any other business that the stockholder proposes to bring before the meeting, (1) a brief description of the business
      desired to be brought before the meeting, (2) the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the Bylaws, the language of the
      proposed amendment), (3) the reasons for conducting such business at the meeting, (4) a reasonably detailed description of all agreements, arrangements and understandings (x) between or among any of the Proposing Persons or (y) between or among any
      Proposing Person and any other person or entity (including their names) in connection with the proposal of such business by such stockholder and (5) any other information relating to such item of business that would be required to be disclosed in a
      proxy statement or other filing required to be made in connection with solicitations of proxies in support of the business proposed to be brought before the meeting pursuant to Section 14(a) of the Exchange Act;</div>
    <div style="font-size: 10pt;">
      <div>&#160;</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(C) as to the Proposing Person, (1) the name and address of such Proposing Person, and, if such Proposing Person is a stockholder
      of record, such name and address must be as they appear on the Corporation&#8217;s books, (2) the class or series and number of shares of the Corporation that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule
      13d-3 under the Exchange Act) by such Proposing Person, except that such Proposing Person shall in all events be deemed to beneficially own any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire
      beneficial ownership at any time in the future, (3) the date or dates such shares were acquired, and (4) any pledge by such Proposing Person with respect to any of such shares;</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(D) as to the stockholder delivering the notice, a representation that such stockholder is a holder of record of stock of the
      Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business or nomination; and</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(E) as to the Proposing Person, (1) a description of any agreement, arrangement or understanding (including any derivative or short
      positions, profit interests, options, warrants, convertible securities, stock appreciation or similar rights, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the stockholder&#8217;s notice by, or on behalf
      of, such stockholder, beneficial owners and Stockholder Related Persons, whether or not such instrument or right shall be subject to settlement in underlying shares of capital stock of the Corporation, the effect or intent of which is to mitigate
      loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power of, such stockholder, beneficial owner or Stockholder Related Persons, with respect to securities of the Corporation&#160; (&#8220;Synthetic Equity Position&#8221;),
      (2) any other information relating to such Proposing Person, if any, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the
      election of directors in an election contest pursuant to and in accordance with Section 14(a) of the Exchange Act, (3) a description of any proxy (other than a revocable proxy given in response to a public proxy solicitation made pursuant to, and in
      accordance with, the Exchange Act), agreement, arrangement, understanding or relationship pursuant to which such Proposing Person has or shares a right, directly or indirectly, to vote any shares of any class or series of capital stock of the
      Corporation, (4) any material pending or threatened legal proceeding in which such Proposing Person is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (5) any other
      material relationship between such Proposing Person, on the one hand, and the Corporation or any affiliate of the Corporation, on the other hand, (6) any direct or indirect material interest in any material contract or agreement of such Proposing
      Person with the Corporation or any affiliate of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement), (7) any proportionate interest in shares of the Corporation or a
      Synthetic Equity Position held, directly or indirectly, by a general or limited partnership, limited liability company or similar entity in which any such Proposing Person (x) is a general partner or, directly or indirectly, beneficially owns an
      interest in a general partner of such general or limited partnership or (y) is the manager, managing member or, directly or indirectly, beneficially owns an interest in the manager or managing member of such limited liability company or similar
      entity, (8) a description of any agreement, arrangement or understanding with respect to the nomination or proposal between or among such Proposing Person, and any other person, including, in the case of a nomination, the nominee, including any
      agreements, arrangements or understandings relating to any compensation or payments to be paid to any such proposed nominee(s), pertaining to the nomination(s) or other business proposed to be brought before the meeting of stockholders (which
      description shall identify the name of each other person who is party to such an agreement, arrangement or understanding), and (9) a representation that such Proposing Person intends or is part of a group which intends (x) to deliver a proxy
      statement and/or form of proxy to holders of at least the percentage of the Corporation&#8217;s outstanding capital stock required to approve or adopt the proposal or elect the nominee, (y) otherwise to solicit proxies or votes from stockholders in support
      of such proposal or nomination, and/or (z) to solicit proxies in support of any proposed nominee in accordance with Rule 14a-19 promulgated under the Exchange Act.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The disclosures to be made pursuant to the clauses set forth in Section 2.03(a)(ii)(E) are referred to as &#8220;Disclosable Interests&#8221;. Notwithstanding
      anything to the contrary, the Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who otherwise would be required
      to disclose Disclosable Interests hereunder solely as a result of being the stockholder directed to prepare and submit the notice required by this Section 2.03 on behalf of a beneficial owner.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;">(iii)&#160;&#160;&#160;&#160; &#160;&#160; The notice requirements set forth in Section 2.03(a)(ii) shall be deemed satisfied by a stockholder with respect to business other than a nomination if the stockholder has notified the
      Corporation of his, her or its intention to present a proposal at an annual meeting in compliance with applicable rules and regulations promulgated under the Exchange Act and such stockholder&#8217;s proposal has been included in a proxy statement that has
      been prepared by the Corporation to solicit proxies for such annual meeting.&#160; The Board of Directors may request any Proposing Person or proposed nominee to furnish such other information as may be reasonably required by the Board of Directors to
      determine whether (a) any proposed nominee is qualified under the Certificate of Incorporation, these Bylaws, the rules or regulations of any stock exchange applicable to the Corporation, or any law or regulation applicable to the Corporation to
      serve as a director and/or independent director of the Corporation or (b) any proposed business (other than the nominations of persons for election to the Board of Directors) constitutes a proper matter for stockholder action.&#160; Such Proposing Person
      shall provide such additional information within ten (10) days after it has been requested by the Board of Directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Notwithstanding anything in the second
          sentence of Section 2.03(a)(ii) to the contrary, in the event that the number of directors to be elected to the Board of Directors at the annual meeting is increased effective after the time period for which nominations would otherwise be due
          under Section 2.03(a)(ii) and there is no public announcement by the Corporation naming the nominees for the additional directorships at least one hundred (100) days prior to the first anniversary of the preceding year&#8217;s annual meeting, a
          stockholder&#8217;s notice required by this Section 2.03 shall also be considered timely, but only with respect to nominees for the additional directorships, if it shall be delivered to the Secretary at the principal executive offices of the
          Corporation not later than the close of business on the tenth (10th) day following the day on which such public announcement is first made by the Corporation.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">For purposes of this Section 2.03, the
          term &#8220;Proposing Person&#8221; shall mean (i) the stockholder providing the notice of business proposed to be brought before a meeting, (ii) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to
          be brought before the meeting is made, and (iii) any participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3 to Item 4 of Schedule 14A) with such stockholder in such solicitation.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160; &#160; <u></u><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Special Meetings of Stockholders</u></font>.&#160; Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the Corporation&#8217;s notice of meeting.&#160; Nominations
          of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the Corporation&#8217;s notice of meeting (1) by or at the direction of the Board of Directors or (2)
          provided that the Board of Directors calling such special meeting pursuant to the Certificate of Incorporation has determined that directors shall be elected at such meeting, by any stockholder of the Corporation who is a stockholder of record at
          the time the notice provided for in this Section 2.03 is delivered to the Secretary of the Corporation and at the time of the meeting, who is entitled to vote at the meeting and upon such election and who complies with the notice procedures set
          forth in this Section 2.03.&#160; The number of nominees a Proposing Person may nominate for election at the special meeting at which directors are to be elected shall not exceed the number of directors to be elected at such special meeting.&#160; In the
          event a special meeting of stockholders is duly called for the purpose of electing one or more directors to the Board of Directors, any such stockholder entitled to vote in such election of directors may nominate a person or persons (as the case
          may be) for election to such position(s) as specified in the Corporation&#8217;s notice of meeting, if the stockholder&#8217;s notice required by Section 2.03(a)(ii) shall be delivered to the Secretary at the principal executive offices of the Corporation
          not earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the close of business on the later of the ninetieth (90th) day prior to such special meeting or the tenth (10th) day following the day on
          which the Corporation first makes a public announcement of the date of the special meeting at which directors are to be elected.&#160; In no event shall the public announcement of an adjournment, recess or postponement of a special meeting commence a
          new time period (or extend any time period) for the giving of a stockholder&#8217;s notice as described above.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160; &#160;&#160; &#160;&#160; <u></u><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>General</u></font>.&#160; (i) Except as otherwise expressly provided in any applicable rule or regulation promulgated under the Exchange Act, only such persons who are nominated in accordance with the procedures set forth in this
          Section 2.03 shall be eligible to be elected at an annual or special meeting of stockholders of the Corporation to serve as directors and only such business shall be conducted at a meeting of stockholders as shall have been brought before the
          meeting in accordance with the procedures set forth in this Section 2.03.&#160; Except as otherwise provided by law, at any meeting of stockholders the chairperson of the meeting (or, in advance of any meeting of stockholders, the Board of Directors
          or an authorized committee thereof) shall (A) determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in this Section 2.03
          (including whether the Proposing Person solicited (or is part of a group which solicited) or did not so solicit, as the case may be, proxies or votes in support of such Proposing Person&#8217;s nominee or proposal in compliance with such Proposing
          Person&#8217;s representation as required by Section 2.03(a)(ii)(E)(9)) and (B) if any proposed nomination or business was not made or proposed in compliance with this Section 2.03, declare that such nomination shall be disregarded or that such
          proposed business shall not be transacted.&#160; Notwithstanding the foregoing provisions of this Section 2.03, unless otherwise required by law, if the Proposing Person (or a qualified representative of the stockholder) does not appear at the annual
          or special meeting of stockholders of the Corporation to present a nomination or proposed business advanced by such Proposing Person, such nomination shall be disregarded and such proposed business shall not be transacted, notwithstanding that
          such proposal or nomination is set forth in the notice of meeting or other proxy materials and notwithstanding that proxies in respect of such vote may have been received by the Corporation.&#160; For purposes of this Section 2.03, to be considered a
          qualified representative of the Proposing Person, a person must be a duly authorized officer, manager or partner of such Proposing Person or must be authorized by a writing executed by such Proposing Person or an electronic transmission delivered
          by such Proposing Person to act for such Proposing Person as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the
          meeting of stockholders.&#160; Notwithstanding anything to the contrary in these Bylaws, unless otherwise required by law, if any Proposing Person (1) provides notice pursuant to Rule 14a-19(b) promulgated under the Exchange Act with respect to any
          proposed nominee and (2) subsequently fails to comply with the requirements of Rule 14a-19 promulgated under the Exchange Act (or fails to timely provide reasonable evidence sufficient to satisfy the Corporation that such stockholder has met the
          requirements of Rule 14a-19(a)(3) promulgated under the Exchange Act in accordance with the following sentence), then the nomination of each such proposed nominee shall be disregarded, notwithstanding that the nominee is included as a nominee in
          the Corporation&#8217;s proxy statement, notice of meeting or other proxy materials for any annual meeting (or any supplement thereto) and notwithstanding that proxies or votes in respect of the election of such proposed nominees may have been received
          by the Corporation (which proxies and votes shall be disregarded).&#160; If any Proposing Person provides notice pursuant to Rule 14a-19(b) promulgated under the Exchange Act, such stockholder shall deliver to the Corporation, no later than seven (7)
          business days prior to the applicable meeting, reasonable evidence that such Proposing Person has met the requirements of Rule 14a-19(a)(3) promulgated under the Exchange Act.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">For purposes of this Section 2.03,
          &#8220;public announcement&#8221; shall include disclosure in a press release reported by the Dow Jones News Service, Associated Press or other national news service or in a document publicly filed by the Corporation with the Securities and Exchange
          Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act.</font></font></div>
    <div style="font-size: 10pt; text-indent: 9pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding the foregoing
          provisions of this Section 2.03, a stockholder shall also comply with all applicable requirements of the Exchange Act with respect to the matters set forth in this Section 2.03; provided however, that any references in these Bylaws to the
          Exchange Act are not intended to and shall not limit any requirements applicable to nominations or proposals as to any other business to be considered pursuant to this Section 2.03 (including Section 2.03(a)(i)(C) and Section 2.03(b) hereof), and
          compliance with Section 2.03(a)(i)(C) and Section 2.03(b) shall be the exclusive means for a stockholder to make nominations or submit other business (other than, as provided in the penultimate sentence of Section 2.03(a)(ii), business other than
          nominations brought properly under and in compliance with Rule 14a-8 of the Exchange Act).&#160; Nothing in this Section 2.03 shall be deemed to affect any rights (A) of stockholders to request inclusion of proposals other than nominations in the
          Corporation&#8217;s proxy statement pursuant to applicable rules and regulations promulgated under the Exchange Act or (B) of the holders of any series of Preferred Stock to elect directors pursuant to any applicable provisions of the Certificate of
          Incorporation.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';">A stockholder providing notice of a
          proposed nomination for election to the Board of Directors or other business proposed to be brought before a meeting (given pursuant to Section 2.03(a)(i) or Section 2.03(b), as applicable) and a candidate for nomination shall promptly update and
          supplement such materials delivered pursuant to this Section 2.03 from time to time to the extent necessary so that the information provided or required to be provided in such notice pursuant to Section 2.03 (other than the representation made in
          Section 2.03(a)(ii)(E)(9) which cannot be changed pursuant to any update) shall be true and correct (x) as of the record date for notice and voting at the meeting and (y) as of the date that is fifteen (15) days prior to the meeting or any
          adjournment or postponement thereof.&#160; Any such update and supplement shall be delivered in writing to the Secretary of the Corporation at the principal executive offices of the Corporation (1) in the case of any update and supplement required to
          be made as of the record date for notice of the meeting, not later than five (5) days after the later of such record date and the public announcement of such record date and (2) in the case of any update or supplement required to be made as of
          fifteen (15) days prior to the meeting or adjournment or postponement thereof, not later than ten (10) days prior to the date for the meeting or any adjournment or postponement thereof.&#160; For the avoidance of doubt, the obligation to update and
          supplement as set forth in <font style="font-family: 'Times New Roman';">this Section </font>2.03 or any other section of these Bylaws shall not limit the Corporation&#8217;s rights with respect to any deficiencies in any stockholder's notice,
          including, without limitation, any representation required herein, extend any applicable deadlines under these Bylaws or enable or be deemed to permit a stockholder who has previously submitted a stockholder's notice under these Bylaws to amend
          or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business or resolutions proposed to be brought before a meeting of stockholders.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';">For purposes of this Section 2.03, the
          following terms have the following meanings:</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(A)</font><font style="font-size: 10pt;"> &#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman';">&#8220;affiliates&#8221; and &#8220;associates&#8221; shall
          have the meanings set forth in Rule 405 under the Securities Act of 1933, as amended;</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 67.5pt; margin-left: 4.5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(B)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;business day&#8221;
          means any day other than Saturday, Sunday or a day on which banks are closed in New York City, New York; and</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 67.5pt; margin-left: 4.5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(C)</font><font style="font-size: 10pt;">&#160; &#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">&#8220;close of
          business&#8221; means 5:00 p.m. local time at the principal executive offices of the Corporation on any calendar day, whether or not the day is a business day.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.04&#160; &#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Notice of Meetings</u></font>. Whenever stockholders are required or permitted
      to take any action at a meeting, a timely notice in writing or by electronic transmission of the meeting, which shall state the place, if any, date and time of the meeting, the means of remote communications, if any, by which stockholders and
      proxyholders may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to
      notice of the meeting, and, in the case of a special meeting, the purposes for which the meeting is called, shall be mailed to or transmitted electronically by the Secretary or other authorized officer of the Corporation to each stockholder of record
      entitled to vote thereat as of the record date for determining the stockholders entitled to notice of the meeting. Unless otherwise provided by law, the Certificate of Incorporation or these Bylaws, the notice of any meeting shall be given not less
      than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.05&#160; &#160; &#160; &#160; <u></u><font style="font-family: 'Times New Roman';"><u>Quorum</u></font>. Unless otherwise required by law, the Certificate of
      Incorporation, these Bylaws or the rules of any stock exchange upon which the Corporation&#8217;s securities are listed, the holders of record of one third of the voting power of the issued and outstanding shares of capital stock of the Corporation
      entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of stockholders. Notwithstanding the foregoing, where a separate vote by a class or series or classes or
      series is required, one third in voting power of the outstanding shares of such class or series or classes or series, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to the vote on that
      matter. Once a quorum is present, it shall not be broken by the subsequent withdrawal of any stockholders.&#160; Shares of the Corporation&#8217;s capital stock shall neither be entitled to vote nor counted for quorum purposes if such shares belong to (i) the
      Corporation, (ii) another corporation, if a majority of the shares entitled to vote in the election of directors of such other corporation is held, directly or indirectly, by the Corporation or (iii) any other entity, if a majority of the voting
      power of such other entity is otherwise controlled, directly or indirectly, by the Corporation; provided, however, that the foregoing shall not limit the right of the corporation to vote stock, including but not limited to its own stock, held by it
      in a fiduciary capacity. If, however, a quorum is not present or represented at any meeting of the stockholders, then either (i) the person presiding over the meeting or (ii) a majority in voting power of the stockholders entitled to vote thereon,
      present in person, or by remote communication, if applicable, or represented by proxy, shall have power to recess the meeting or adjourn the meeting from time to time in the manner provided in Section 2.10 of these Bylaws until a quorum is present or
      represented.&#160; At any recessed or adjourned meeting at which a quorum is present or represented, any business may be transacted that might have been transacted at the meeting as originally noticed.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.06&#160; &#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Voting; Proxies</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 45pt; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as otherwise provided by or pursuant to the
        provisions of the Certificate of Incorporation, each stockholder entitled to vote at any meeting of stockholders shall be entitled to one vote for each share of stock held by such stockholder which has voting power upon the matter in question. Any
        matter, other than the election of directors, brought before any meeting of stockholders at which a quorum is present shall be decided by the affirmative vote of the majority the votes cast on the matter<font style="font-family: 'Times New Roman'; font-weight: bold;">, </font>unless a different or minimum vote is required by the Certificate of Incorporation, these Bylaws, the rules or regulations of any stock exchange applicable to the Corporation, or any law or regulation applicable to
        the Corporation or its securities, in which case such different or minimum vote shall be the applicable vote on the matter.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">At all meetings of
          stockholders for the election of directors at which a quorum is present a plurality of the votes cast shall be sufficient to elect.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Unless required by
          the Certificate of Incorporation or applicable law, or determined by the Board of Directors or the chairperson of the meeting to be advisable, the vote on any question need not be by written ballot. On a vote by written ballot, each ballot shall
          be signed by the stockholder voting, or by such stockholder&#8217;s proxy, if there be such proxy.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 45pt; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160; &#160;&#160; Each stockholder entitled to vote at a meeting of
        stockholders or to express consent to corporate action in writing without a meeting may authorize another person or persons to act for such stockholder by proxy in any manner provided by applicable law, but no such proxy shall be voted or acted
        upon after three (3) years from its date, unless the proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and only as long as, it is coupled with an interest sufficient in law to support an
        irrevocable power. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by delivering to the Secretary of the Corporation a revocation of the proxy or a new proxy bearing a later date.</font></div>
    <div style="font-size: 10pt; text-indent: 9pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Any stockholder directly or indirectly
          soliciting proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use by the Board of Directors.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.07&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Chairperson of Meetings</u></font>. The Chairperson of the Board of Directors, if
      one is appointed, or, in his or her absence or disability, the Chief Executive Officer of the Corporation, or in the absence of the Chairperson of the Board of Directors and the Chief Executive Officer, a person designated by the Board of Directors
      shall be the chairperson of the meeting of stockholders and, as such, preside at all meetings of the stockholders.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.08&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Secretary of Meetings</u></font>. The Secretary of the Corporation shall act as
      secretary at all meetings of the stockholders. In the absence or disability of the Secretary, the Chairperson of the Board of Directors or the Chief Executive Officer shall appoint a person to act as Secretary at such meetings.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.09&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Consent of Stockholders in Lieu of Meeting</u></font>. Any action required or
      permitted to be taken at any annual or special meeting of stockholders of the Corporation may be taken without a meeting, without prior notice and without a vote only to the extent permitted by and in the manner provided in the Certificate of
      Incorporation and in accordance with applicable law.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.10&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Adjournment</u></font>. Any meeting of stockholders, annual or special, and whether
      or not there is a quorum, may adjourn from time to time to reconvene at the same or some other place, and notice need not be given of any such adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is
      taken or are provided in any other manner permitted by the DGCL.&#160; At the adjourned meeting the Corporation may transact any business which might have been transacted at the original meeting.&#160; If the adjournment is for more than thirty (30) days, a
      notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.&#160; If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting, the Board
      of Directors shall fix as the record date for determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall give
      notice of the adjourned meeting to each stockholder of record entitled to vote at the adjourned meeting as of the record date so fixed for notice of such adjourned meeting.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.11&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Conduct of Business</u></font>.&#160; The date and time of the opening and the closing
      of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting by the person presiding over the meeting.&#160; The Board of Directors may adopt by resolution such rules and regulations for the conduct of
      the meeting of stockholders as it shall deem appropriate.&#160; Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the person presiding over any meeting of stockholders shall have the right and
      authority to convene and (for any or no reason) to recess and/or adjourn the meeting, to prescribe such rules, regulations and procedures (which need not be in writing) and to do all such acts as, in the judgment of such presiding person, are
      appropriate for the proper conduct of the meeting.&#160; Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the person presiding over the meeting, may include, without limitation, the following: (i) the
      establishment of an agenda or order of business for the meeting; (ii) rules and procedures for maintaining order at the meeting and the safety of those present (including, without limitation, rules and procedures for removal of disruptive persons
      from the meeting); (iii) limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies or such other persons as the person presiding over the meeting shall
      determine; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (v) limitations on the time allotted to questions or comments by participants. The presiding person at any meeting of stockholders, in
      addition to making any other determinations that may be appropriate to the conduct of the meeting (including, without limitation, determinations with respect to the administration and/or interpretation of any of the rules, regulations or procedures
      of the meeting, whether adopted by the Board of Directors or prescribed by the person presiding over the meeting), shall, if the facts warrant, determine and declare to the meeting that a matter of business was not properly brought before the meeting
      and if such presiding person should so determine, such presiding person shall so declare to the meeting and any such matter or business not properly brought before the meeting shall not be transacted or considered. Unless and to the extent determined
      by the Board of Directors or the person presiding over the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.12&#160;&#160;&#160; <u></u><font style="font-family: 'Times New Roman';"><u>Remote Communication</u></font>. If authorized by the Board of Directors in
      its sole discretion, and subject to such guidelines and procedures as the Board of Directors may adopt, stockholders and proxy holders not physically present at a meeting of stockholders may, by means of remote communication:</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;participate in a meeting of stockholders; and</font></div>
    <div style="font-size: 10pt; text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; font-size: 10pt; text-indent: 72pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; be deemed present in person and vote at a meeting of stockholders
        whether such meeting is to be held at a designated place or solely by means of remote communication, provided, that</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the Corporation shall implement
          reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or proxyholder;</font></font></div>
    <div style="font-size: 10pt; text-indent: 9pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the Corporation shall implement
          reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting
          substantially concurrently with such proceedings; and</font></font></div>
    <div style="font-size: 10pt; text-indent: 9pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 45pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160; &#160; &#160; if any stockholder or proxyholder votes or takes other action at the meeting
        by means of remote communication, a record of such vote or other action shall be maintained by the Corporation.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.13&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Inspectors of Election</u></font>. The Corporation may, and shall if required by
      law, in advance of any meeting of stockholders, appoint one or more inspectors of election, who may be employees of the Corporation, to act at the meeting or any adjournment thereof and to make a written report thereof. The Corporation may designate
      one or more persons as alternate inspectors to replace any inspector who fails to act. In the event that no inspector so appointed or designated is able to act at a meeting of stockholders, the chairperson of the meeting shall appoint one or more
      inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according to the best of his or her
      ability. The inspectors so appointed or designated shall (i) ascertain the number of shares of capital stock of the Corporation outstanding and the voting power of each such share, (ii) determine the shares of capital stock of the Corporation
      represented at the meeting and the validity of proxies and ballots, (iii) count all votes and ballots, (iv) determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors, and
      (v) certify their determination of the number of shares of capital stock of the Corporation represented at the meeting and such inspectors&#8217; count of all votes and ballots. Such certification and report shall specify such other information as may be
      required by law. In determining the validity and counting of proxies and ballots cast at any meeting of stockholders of the Corporation, the inspectors may consider such information as is permitted by applicable law. No person who is a candidate for
      an office at an election may serve as an inspector at such election.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 2.14</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Delivery to the Corporation</u></font>. Whenever Section 2.03 requires one or more persons (including a record or beneficial owner of stock) to deliver a document or information to the Corporation or any officer, employee or
          agent thereof (including any notice, request, questionnaire, revocation, representation or other document or agreement), such document or information shall be in writing exclusively (and not in an electronic transmission) and shall be delivered
          exclusively by hand (including, without limitation, overnight courier service) or by certified or registered mail, return receipt requested, and the Corporation shall not be required to accept delivery of any document not in such written form or
          so delivered. For the avoidance of doubt, the Corporation expressly opts out of Section 116 of the DGCL with respect to the delivery of information and documents to the Corporation required by Section 2.03.</font></font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE III.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BOARD OF DIRECTORS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.01&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Powers</u></font>. Except as otherwise provided by the Certificate of
      Incorporation, these Bylaws or the DGCL, the business and affairs of the Corporation shall be managed by or under the direction of its Board of Directors. The Board of Directors may exercise all such authority and powers of the Corporation and do all
      such lawful acts and things as are not by the DGCL or the Certificate of Incorporation directed or required to be exercised or done by the stockholders.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.02&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Number and Term; Chairperson</u></font>. Subject to the Certificate of
      Incorporation, the number of directors shall consist of one or more directors and the total number of directors shall be determined from time to time exclusively by resolution adopted by the Board of Directors. Directors shall be elected by the
      stockholders at their annual meeting.&#160; Each director shall hold office until next annual meeting of stockholders and until his or her successor shall be elected and qualified, or his or her earlier death, resignation, retirement, disqualification or
      removal from office.&#160; Directors need not be stockholders.&#160; The Board of Directors shall elect a Chairperson of the Board of Directors, who shall have the powers and perform such duties as provided in these Bylaws and as the Board of Directors may
      from time to time prescribe. The Chairperson of the Board of Directors shall preside at all meetings of the Board of Directors at which he or she is present. If the Chairperson of the Board of Directors is not present at a meeting of the Board of
      Directors, the Chairperson may designate another director to preside at such meeting. If the Chairperson of the Board of Directors is not present at a meeting of the Board of Directors and the Chairperson has not designated another director to
      preside at the meeting pursuant to the preceding sentence, the Chief Executive Officer (if the Chief Executive Officer is a director and is not also the Chairperson of the Board of Directors) shall preside at such meeting, and, if the Chief Executive
      Officer is not present at such meeting or is not a director, a majority of the directors present at such meeting shall elect one (1) of their members to preside.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.03&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Resignations</u></font>. Any director may resign at any time upon notice given in
      writing or by electronic transmission to the Board of Directors, the Chairperson of the Board of Directors, the Chief Executive Officer or the Secretary of the Corporation. The resignation shall take effect at the time specified therein, and if no
      time is specified, at the time of its receipt. The acceptance of a resignation shall not be necessary to make it effective unless otherwise expressly provided in the resignation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.04&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Removal</u></font>. Directors of the Corporation may be removed in the manner
      provided in the Certificate of Incorporation and applicable law.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.05&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Vacancies and Newly Created Directorships</u></font>. Except as otherwise provided
      by law, vacancies occurring in any directorship (whether by death, resignation, retirement, disqualification, removal or other cause) and newly created directorships resulting from any increase in the number of directors shall be filled in accordance
      with the Certificate of Incorporation. Any director elected or appointed to fill a vacancy or newly created directorship shall hold office until the next election of directors and until his or her successor shall be elected and qualified, or until
      his or her earlier death, resignation, retirement, disqualification or removal.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.06&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Meetings</u></font>. Regular meetings of the Board of Directors may be held at such
      places and times as shall be determined from time to time by the Board of Directors. Special meetings of the Board of Directors may be called by the Chief Executive Officer of the Corporation or the Chairperson of the Board of Directors, and shall be
      called by the Chief Executive Officer or the Secretary of the Corporation if directed by the Board of Directors and shall be at such place, date and time as may be fixed by the person or persons at whose direction the meeting is called. Notice need
      not be given of regular meetings of the Board of Directors. At least twenty-four (24) hours before each special meeting of the Board of Directors, either written notice, notice by electronic transmission or oral notice (either in person or by
      telephone) of the time, date and place of the meeting shall be given to each director. Unless otherwise indicated in the notice thereof, any and all business may be transacted at a special meeting.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.07&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Quorum and Voting</u></font>. Except as otherwise provided by law, the Certificate
      of Incorporation, or these Bylaws, a majority of the total number of directors shall constitute a quorum for the transaction of business at any meeting of the Board of Directors. Except as otherwise provided by law, the Certificate of Incorporation
      or these Bylaws, the act of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.08&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Committees; Committee Rules</u></font>. The Board of Directors may designate one or
      more committees, each such committee to consist of one or more of the directors of the Corporation as determined by the Board of Directors. The Board of Directors may designate one or more directors as alternate members of any committee to replace
      any absent or disqualified member at any meeting of the committee. Any such committee, to the extent permitted by law and provided in the resolution of the Board of Directors establishing such committee, shall have and may exercise all the powers and
      authority of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it. All committees of the Board of Directors shall keep
      minutes of their meetings and shall report their proceedings to the Board of Directors when requested or required by the Board of Directors. Each committee of the Board of Directors may fix its own rules of procedure and shall hold its meetings as
      provided by such rules, except as may otherwise be provided by a resolution of the Board of Directors designating such committee. Unless otherwise provided in such a resolution, the presence of at least a majority of the members of the committee then
      serving shall be necessary to constitute a quorum unless the committee shall consist of one or two members, in which event one member shall constitute a quorum; and all matters shall be determined by a majority vote of the members present at a
      meeting of the committee at which a quorum is present. Unless otherwise provided in such a resolution, in the event that a member and that member&#8217;s alternate, if alternates are designated by the Board of Directors, of such committee is or are absent
      or disqualified, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting
      in place of any such absent or disqualified member.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.09&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Action Without a Meeting</u></font>. Unless otherwise restricted by the Certificate
      of Incorporation, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting if all members of the Board of Directors or any committee thereof, as the case may be,
      consent thereto in writing or by electronic transmission.&#160; After an action is taken, the consent or consents or electronic transmission or transmissions shall be filed in the minutes of proceedings of the Board of Directors in accordance with
      applicable law. Such filing shall be in paper form if the minutes are maintained in paper form or shall be in electronic form if the minutes are maintained in electronic form.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.10&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Remote Meeting</u></font>. Unless otherwise restricted by the Certificate of
      Incorporation, members of the Board of Directors, or any committee designated by the Board of Directors, may participate in a meeting by means of conference telephone or other communications equipment in which all persons participating in the meeting
      can hear each other. Participation in a meeting by means of conference telephone or other communications equipment shall constitute presence in person at such meeting.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.11&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Compensation</u></font>. The Board of Directors shall have the authority to fix the
      compensation, including fees and reimbursement of expenses, of directors for services to the Corporation in any capacity.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.12&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Reliance on Books and Records</u></font>. A member of the Board of Directors, or a
      member of any committee designated by the Board of Directors shall, in the performance of such person&#8217;s duties, be fully protected in relying in good faith upon records of the Corporation and upon such information, opinions, reports or statements
      presented to the Corporation by any of the Corporation&#8217;s officers or employees, or committees of the Board of Directors, or by any other person as to matters the member reasonably believes are within such other person&#8217;s professional or expert
      competence and who has been selected with reasonable care by or on behalf of the Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IV.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OFFICERS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.01&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Officers.</u></font>&#160; The officers of the Corporation may include a Chief Executive
      Officer, a President, a Chief Financial Officer, a Treasurer, a Secretary, one or more Vice Presidents, and one or more Assistant Treasurers or Assistant Secretaries, each of whom shall, except as otherwise provided in Section 4.02, be elected by the
      Board of Directors and who shall hold office for such terms as shall be determined by the Board of Directors and until their successors are elected and qualify or until their earlier resignation or removal. Any number of offices may be held by the
      same person.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.02.&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Subordinate Officers.</u></font>&#160; The Board of Directors may appoint, or empower the
      Chief Executive Officer, to appoint, such other officers and agents as the business of the Corporation may require.&#160; Each of such officers and agents shall hold office for such period, have such authority, and perform such duties as are provided in
      these Bylaws or as the Board of Directors or, if applicable, the Chief Executive Officer, may from time to time determine.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.03&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Chief Executive Officer</u></font>. The Chief Executive Officer, who may also be
      the President, subject to the determination of the Board of Directors, shall have general executive charge, management, and control of the properties and operations of the Corporation in the ordinary course of its business, with all such powers with
      respect to such properties and operations as may be reasonably incident to such responsibilities. The Chief Executive Officer shall perform other duties commonly incident to the office and shall also perform such other duties and have such other
      powers, as the Board of Directors shall designate from time to time. If the Board of Directors has not appointed a separate Chairperson of the Board of Directors or in the absence or inability to act as the Chairperson of the Board of Directors, the
      Chief Executive Officer shall exercise all of the powers Chairperson and discharge all of the duties of the Chairperson of the Board of Directors, but only if the Chief Executive Officer is a director of the Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.04&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>President and Vice Presidents</u></font>. The President shall have such powers and
      shall perform such duties as shall be assigned to him or her by the Chief Executive Officer or the Board of Directors. Each Vice President, if any are appointed, of whom one or more may be designated an Executive Vice President or Senior Vice
      President, shall have such powers and shall perform such duties as shall be assigned to him or her by the Chief Executive Officer or the Board of Directors. The President and each Vice President shall perform other duties commonly incident to the
      office and shall also perform such other duties and have such other powers, as the Chief Executive Officer or the Board of Directors shall designate from time to time.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.05&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Chief Financial Officer; Treasurer</u></font>. The Chief Financial Officer or such
      other officer performing substantially similar functions, or if none has been appointed, the Treasurer, shall have custody of the corporate funds, securities, evidence of indebtedness and other valuables of the Corporation and shall keep full and
      accurate accounts of receipts and disbursements in books belonging to the Corporation. The Chief Financial Officer or such other officer performing substantially similar functions, or if none has been appointed, the Treasurer, shall deposit all
      moneys and other valuables in the name and to the credit of the Corporation in such depositories as may be designated by (i) the Board of Directors or its designees selected for such purposes or (ii) the Chief Executive Officer, the President or any
      Vice President. The Chief Financial Officer or such other officer performing substantially similar functions and the Treasurer shall perform other duties commonly incident to the office and shall also perform such other duties and have such other
      powers, as the Chief Executive Officer or the Board of Directors shall designate from time to time.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.06&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Secretary</u></font>. The Secretary shall: (a) cause minutes of all meetings of the
      stockholders and directors to be recorded and kept properly; (b) cause all notices required by these Bylaws or otherwise to be given properly; (c) see that the minute books, stock books, and other nonfinancial books, records and papers of the
      Corporation are kept properly; and (d) cause all reports, statements, returns, certificates and other documents to be prepared and filed when and as required. The Secretary shall perform other duties commonly incident to the office and shall also
      perform such other duties and have such other powers, as the Chief Executive Officer or the Board of Directors shall designate from time to time.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.07&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Corporate Funds and Checks</u></font>. The funds of the Corporation shall be kept in
      such depositories as shall from time to time be prescribed by (i) the Board of Directors or its designees selected for such purposes or (ii) the Chief Executive Officer, President or any Vice President, or the Chief Financial Officer or Treasurer.
      All checks or other orders for the payment of money shall be signed by any of the Chief Executive Officer, the President, a Vice President, the Chief Financial Officer, the Treasurer or the Secretary or the Assistant Treasurer or Assistant Secretary
      or such other person or agent as may from time to time be authorized and with such countersignature, if any, as may be required by the Board of Directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.08&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Contracts and Other Documents</u></font>. Any of the Chief Executive Officer, the
      President, a Vice President, the Chief Financial Officer, the Treasurer or the Secretary, or the Assistant Treasurer or Assistant Secretary or such other officer or officers as may from time to time be authorized by the Board of Directors or any
      other committee given specific authority in the premises by the Board of Directors during the intervals between the meetings of the Board of Directors, shall have power to sign and execute on behalf of the Corporation deeds, conveyances and
      contracts, and any and all other documents requiring execution by the Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.09&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Ownership of Stock of Another Entity</u></font>. Unless otherwise directed by the
      Board of Directors, any of the Chief Executive Officer, the President, a Vice President, the Chief Financial Officer, the Treasurer or the Secretary or the Assistant Treasurer or Assistant Secretary, or such other officer or agent as shall be
      authorized by the Board of Directors, shall have the power and authority, on behalf of the Corporation, to attend and to vote at any meeting of securityholders of any entity in which the Corporation holds securities or equity interests and may
      exercise, on behalf of the Corporation, any and all of the rights and powers incident to the ownership of such securities or equity interests at any such meeting, including the authority to execute and deliver proxies and consents on behalf of the
      Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.10&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Delegation of Duties</u></font>. In the absence, disability or refusal of any
      officer to exercise and perform his or her duties, the Board of Directors may delegate to another officer such powers or duties.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.11&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Resignation and Removal</u></font>. Any officer of the Corporation appointed by the
      Board may be removed from office for or without cause at any time by the Board of Directors. Any officer appointed by the Chief Executive Officer may be removed by the Chief Executive Officer or by the Board of Directors.&#160;&#160; Any officer may resign at
      any time in the same manner as prescribed with respect to directors under Section 3.03.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.12&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Vacancies</u></font>. The Board of Directors shall have the power to fill
      vacancies occurring in any office.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE V.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">STOCK</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.01&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Shares With Certificates</u></font>. The shares of stock of the Corporation shall
      be represented by certificates, provided that the Board of Directors may provide by resolution or resolutions that some or all of any or all classes or series of the Corporation&#8217;s stock shall be uncertificated shares. Any such resolution shall not
      apply to shares represented by a certificate until such certificate is surrendered to the Corporation. Every holder of stock in the Corporation represented by certificates shall be entitled to have a certificate signed by, or in the name of the
      Corporation by any two authorized officers of the Corporation (it being understood that each of the Chairperson of the Board of Directors or the Vice Chairperson of the Board of Directors, or the Chief Executive Officer, the President or a Vice
      President, Chief Financial Officer, Treasurer, Assistant Treasurer, Secretary or an Assistant Secretary of the Corporation shall be an authorized officer for such purpose) certifying the number and class of shares of stock of the Corporation owned by
      such holder. Any or all of the signatures on the certificate may be a facsimile or electronic signature. The Board of Directors shall have the power to appoint one or more transfer agents and/or registrars for the transfer or registration of
      certificates of stock of any class, and may require stock certificates to be countersigned or registered by one or more of such transfer agents and/or registrars.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.02&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Shares Without Certificates</u></font>. If the Board of Directors chooses to issue
      shares of stock without certificates, the Corporation, if required by the DGCL, shall, within a reasonable time after the issue or transfer of shares without certificates, send the stockholder a written statement of the information required by the
      DGCL. The Corporation may adopt a system of issuance, recordation and transfer of its shares of stock by electronic or other means not involving the issuance of certificates, provided the use of such system by the Corporation is permitted in
      accordance with applicable law.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.03&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Transfer of Shares</u></font>. Shares of stock of the Corporation represented by
      certificates shall be transferable upon its books by the holders thereof, in person or by their duly authorized attorneys or legal representatives, in the manner prescribed by law, the Certificate of Incorporation, and these Bylaws, upon surrender to
      the Corporation by delivery thereof (to the extent evidenced by a physical stock certificate) to the person in charge of the stock and transfer books and ledgers. Certificates representing such shares, if any, shall be cancelled and new certificates,
      if the shares are to be certificated, shall thereupon be issued. Shares of capital stock of the Corporation that are not represented by a certificate shall be transferred in accordance with any procedures adopted by the Corporation or its agent and
      applicable law. A record shall be made of each transfer. Whenever any transfer of shares shall be made for collateral security, and not absolutely, it shall be so expressed in the entry of the transfer if, when the certificates are presented to the
      Corporation for transfer or uncertificated shares are requested to be transferred, both the transferor and transferee request the Corporation to do so. The Board of Directors shall have power and authority to make such rules and regulations as it may
      deem necessary or proper concerning the issue, transfer and registration of shares of stock of the Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.04&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Lost, Stolen, Destroyed or Mutilated Certificates</u></font>. A new certificate of
      stock or uncertificated shares may be issued in the place of any certificate previously issued by the Corporation alleged to have been lost, stolen or destroyed, and the Corporation may, in its discretion, require the owner of such lost, stolen or
      destroyed certificate, or his or her legal representative, to give the Corporation a bond, in such sum as the Corporation may direct, in order to indemnify the Corporation against any claims that may be made against it in connection therewith. A new
      certificate or uncertificated shares of stock may be issued in the place of any certificate previously issued by the Corporation that has become mutilated upon the surrender by such owner of such mutilated certificate and, if required by the
      Corporation, the posting of a bond by such owner in an amount sufficient to indemnify the Corporation against any claim that may be made against it in connection therewith.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.05&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>List of Stockholders Entitled To Vote</u></font>. The Corporation shall prepare, no
      later than the tenth day before each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting (provided, however, if the record date for determining the stockholders entitled to vote is less than ten (10) days
      before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date), arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in
      the name of each stockholder.&#160; Such list shall be open to the examination of any stockholder for any purpose germane to the meeting for a period of ten (10) days ending on the day before the meeting date (i) on a reasonably accessible electronic
      network, provided that the information required to gain access to such list is provided with the notice of meeting or (ii) during ordinary business hours at the principal place of business of the corporation. In the event that the Corporation
      determines to make the list available on an electronic network, the Corporation shall take reasonable steps to ensure that such information is available only to stockholders of the Corporation. Except as otherwise provided by law, the stock ledger
      shall be the only evidence as to who are the stockholders entitled to examine the list of stockholders required by this Section 5.05 or to vote in person or by proxy at any meeting of stockholders.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.06&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Fixing Date for Determination of Stockholders of Record</u></font>.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 45pt; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In order that the Corporation may determine the stockholders
        entitled to notice of any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of
        Directors, and which record date shall, unless otherwise required by law, not be more than sixty (60) nor less than ten (10) days before the date of such meeting. If the Board of Directors so fixes a date, such date shall also be the record date
        for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such
        determination. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on
        which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall
        apply to any adjournment of the meeting; provided, however, that the Board of Directors may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for
        stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned.</font></div>
    <div style="font-size: 10pt; text-indent: 9pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 72pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; In order that the Corporation may determine the stockholders entitled to
        receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may
        fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall not be more than sixty (60) days prior to such action. If no such record date is fixed, the
        record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 72pt; font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(c)</font>&#160; &#160; &#160; &#160;&#160;&#160; Unless otherwise restricted by the Certificate of Incorporation, in
        order that the Corporation may determine the stockholders entitled to express consent to corporate action without a meeting, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing
        the record date is adopted by the Board of Director, and which record date shall not be more than ten (10) days after the date upon which the resolutions fixing the record date is adopted by the Board of Directors. If no record date for determining
        stockholders entitled to express consent to corporate action without a meeting is fixed by the Board of Directors, (i) when no prior action of the Board of Directors is required by law, the record date for such purpose shall be the first date on
        which a signed consent setting forth the action taken or proposed to be taken is delivered to the Corporation in accordance with applicable law, and (ii) if prior action by the Board of Directors is required by law, the record date for such purpose
        shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action.</font></div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.07&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Registered Stockholders</u></font>. Prior to the surrender to the Corporation of
      the certificate or certificates for a share or shares of stock or notification to the Corporation of the transfer of uncertificated shares with a request to record the transfer of such share or shares, the Corporation may treat the registered owner
      of such share or shares as the person entitled to receive dividends, to vote, to receive notifications and otherwise to exercise all the rights and powers of an owner of such share or shares. To the fullest extent permitted by law, the Corporation
      shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VI.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTICE AND WAIVER OF NOTICE</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 6.01&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Notice</u></font>. If mailed, notice to stockholders shall be deemed given when
      deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder&#8217;s address as it appears on the records of the Corporation and if given by any other form, including any form of electronic transmission, permitted
      by the DGCL, shall be deemed given as provided in the DGCL. Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders may be given by electronic transmission in the manner provided in
      Section 232 of the DGCL.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 6.02&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Waiver of Notice</u></font>. A written waiver of any notice, signed by a
      stockholder or director, or waiver by electronic transmission by such person, whether given before or after the time of the event for which notice is to be given, shall be deemed equivalent to the notice required to be given to such person. Neither
      the business nor the purpose of any meeting need be specified in such a waiver. Attendance at any meeting (in person or by remote communication) shall constitute waiver of notice except attendance for the express purpose of objecting at the beginning
      of the meeting to the transaction of any business because the meeting is not lawfully called or convened.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VII.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INDEMNIFICATION</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.01&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Right to Indemnification</u></font>. Each person who was or is made a party or is
      threatened to be made a party to or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a &#8220;proceeding&#8221;), by reason of the fact that he or she is or was a director or an
      officer of the Corporation or, while serving as a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, agent or trustee of another corporation or of a partnership, joint
      venture, trust or other enterprise, including service with respect to an employee benefit plan (hereinafter an &#8220;indemnitee&#8221;), whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee, agent or
      trustee or in any other capacity while serving as a director, officer, employee, agent or trustee, shall be indemnified and held harmless by the Corporation to the fullest extent permitted by law, as the same exists or may hereafter be amended
      against all expense, liability and loss (including attorneys&#8217; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) actually and reasonably incurred or suffered by such indemnitee in connection therewith; provided,
      however, that, except as provided in Section 7.03 with respect to proceedings to enforce rights to indemnification or advancement of expenses or with respect to any compulsory counterclaim brought by such indemnitee, the Corporation shall indemnify
      any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.02&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Right to Advancement of Expenses</u></font>. In addition to the right to
      indemnification conferred in Section 7.01, an indemnitee shall also have the right to be paid by the Corporation the expenses (including attorney&#8217;s fees) incurred by indemnitee in appearing at, participating in or defending any such proceeding in
      advance of its final disposition or in connection with a proceeding brought to establish or enforce a right to indemnification or advancement of expenses under this Article VII (which shall be governed by Section 7.03 (hereinafter an &#8220;advancement of
      expenses&#8221;)); provided, however, that, if the DGCL requires or in the case of an advancement of expenses made in a proceeding brought to establish or enforce a right to indemnification or advancement of expenses, an advancement of expenses incurred by
      an indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made solely upon
      delivery to the Corporation of an undertaking (hereinafter an &#8220;undertaking&#8221;), by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to
      appeal (hereinafter a &#8220;final adjudication&#8221;) that such indemnitee is not entitled to be indemnified under Sections 7.01 and 7.02 or otherwise.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.03&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Right of Indemnitee to Bring Suit</u></font>. If a claim under Section 7.01 or 7.02
      is not paid in full by the Corporation within (i) 60 days after a written claim for indemnification has been received by the Corporation or (ii) 20 days after a claim for an advancement of expenses has been received by the Corporation, the indemnitee
      may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim or to obtain advancement of expenses, as applicable. To the fullest extent permitted by law, if indemnitee is successful in whole or in part in
      any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In any suit
      brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense that the indemnitee has not met the applicable standard for
      indemnification set forth in the DGCL In any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that the
      indemnitee has not met the applicable standard for indemnification set forth in the DGCL. Neither the failure of the Corporation (including by its directors who are not parties to such action, a committee of such directors, independent legal counsel,
      or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the DGCL,
      nor an actual determination by the Corporation (including by its directors who are not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of
      conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct. In any suit brought by the indemnitee to enforce a right to indemnification or to an advancement of expenses hereunder, or brought by the
      Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article VII or otherwise shall be
      on the Corporation.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.04&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Indemnification Not Exclusive</u></font>.&#160; The provision of indemnification to or
      the advancement of expenses and costs to any indemnitee under this Article VII, or the entitlement of any indemnitee to indemnification or advancement of expenses and costs under this Article VII, shall not limit or restrict in any way the power of
      the Corporation to indemnify or advance expenses and costs to such indemnitee in any other way permitted by law or be deemed exclusive of, or invalidate, any right to which any indemnitee seeking indemnification or advancement of expenses and costs
      may be entitled under any law, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such indemnitee&#8217;s capacity as an officer, director, employee or agent of the Corporation and as to action in any other
      capacity.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.05&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Nature of Rights</u></font>. The rights granted pursuant to the provisions of this
      Article VII shall vest at the time a person becomes a director or officer of the Corporation and shall be deemed to create a binding contractual obligation on the part of the Corporation to the persons who from time to time are elected as officers or
      directors of the Corporation, and such persons in acting in their capacities as officers or directors of the Corporation or any subsidiary shall be entitled to rely on such provisions of this Article VII without giving notice thereof to the
      Corporation. Such rights shall continue as to an indemnitee who has ceased to be a director or officer and shall inure to the benefit of the indemnitee&#8217;s heirs, executors and administrators. Any amendment, alteration or repeal of this Article VII
      that adversely affects any right of an indemnitee or its successors shall be prospective only and shall not limit, eliminate, or impair any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action or
      omission to act that took place prior to such amendment, alteration or repeal.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.06&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Insurance</u></font>. The Corporation may purchase and maintain insurance, at its
      expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have
      the power to indemnify such person against such expense, liability or loss under the DGCL.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 7.07&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Indemnification of Employees and Agents of the Corporation</u></font>. The
      Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation and to any person (in addition to an indemnitee)
      serving at the request of the Corporation as a director, officer, employee or agent of another enterprise to the fullest extent of the provisions of this Article VII with respect to the indemnification and advancement of expenses of directors and
      officers of the Corporation. Any reference to an officer of the Corporation in this Article VII shall be deemed to refer exclusively to an officer of the Corporation elected by the Board of Directors or the Chief Executive Officer pursuant to Article
      IV, and any reference to an officer of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall be deemed to refer exclusively to an officer elected by the board of directors or equivalent governing
      body of such other entity pursuant to the certificate of incorporation and bylaws or equivalent organizational documents of such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise. The fact that any person
      who is or was an employee of the Corporation or an employee of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise has been given or has used the title of &#8220;Vice President&#8221; or any other title that could
      be construed to suggest or imply that such person is or may be an officer of the Corporation or of such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall not result in such person being constituted
      as, or being deemed to be, an officer of the Corporation or of such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise for purposes of this Article VII.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VIII.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MISCELLANEOUS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 8.01&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Electronic Transmission</u></font>. For purposes of these Bylaws, &#8220;electronic
      transmission&#8221; means any form of communication, not directly involving the physical transmission of paper, including the use of, or participation in, one or more electronic networks or databases (including one or more distributed networks or
      databases), that creates a record that may be retained, retrieved, and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 8.02&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Corporate Seal</u></font>. The Board of Directors may provide a suitable seal,
      containing the name of the Corporation, which seal shall be in the charge of the Secretary. If and when so directed by the Board of Directors or a committee thereof, duplicates of the seal may be kept and used by the Treasurer or by an Assistant
      Secretary or Assistant Treasurer.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 8.03&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Fiscal Year</u></font>. The fiscal year of the Corporation shall end on March 31,
      or such other day as the Board of Directors may designate.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 8.04&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Section Headings</u></font>. Section headings in these Bylaws are for convenience
      of reference only and shall not be given any substantive effect in limiting or otherwise construing any provision herein.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Section 8.05&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Inconsistent Provisions</u></font>. In the event that any provision of these Bylaws
      is or becomes inconsistent with any provision of the Certificate of Incorporation, the DGCL or any other applicable law, such provision of these Bylaws shall not be given any effect to the extent of such inconsistency but shall otherwise be given
      full force and effect.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">23</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IX.</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AMENDMENTS</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Board of Directors is authorized to make, repeal, alter, amend and rescind, in whole or in part, these Bylaws without the assent or vote of the
      stockholders in any manner not inconsistent with the laws of the State of Delaware or the Certificate of Incorporation. Notwithstanding any other provisions of these Bylaws, in addition to any vote of the holders of any class or series of the stock
      of this Corporation required by law, the Certificate of Incorporation or these Bylaws, the affirmative vote of the holders of at least a majority of the voting power of all the then-outstanding shares of stock of the Corporation entitled to thereon,
      voting together as a single class, shall be required in order for the stockholders of the Corporation to alter, amend, repeal or rescind, in whole or in part, any provision of these Bylaws (including, without limitation, this Article IX) or to adopt
      any provision inconsistent herewith.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE X</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FORUM</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Unless the Corporation consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or if such court
      does not have subject matter jurisdiction another state or federal court (as appropriate) located within the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action or proceeding
      brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee, or stockholder of the Corporation to the Corporation or the Corporation&#8217;s
      stockholders, creditors or other constituents, (iii) any action asserting a claim against the Corporation or any current or former director, officer, employee, or stockholder of the Corporation arising pursuant to any provision of the DGCL or the
      Certificate of Incorporation or these Bylaws (as either may be amended and/or restated from time to time) or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, or (iv) any action asserting a claim governed by
      the internal affairs doctrine.&#160; Unless the Corporation consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America shall be the exclusive forum for
      the resolution of any complaint asserting a cause of action arising under the federal securities laws of the United States of America.&#160; To the fullest extent permitted by law, any person or entity purchasing or otherwise acquiring or holding any
      interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Article X.&#160; Notwithstanding the foregoing, the provisions of this Article X shall not apply to suits brought to enforce
      any liability or duty created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts of the United States have exclusive jurisdiction.</div>
    <div style="font-size: 10pt;">&#160;</div>
    <div style="font-size: 10pt;"><br>
    </div>
    <div style="font-size: 10pt; text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">24</font></div>
    <div style="font-size: 10pt;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>grce-20241024.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<xs:schema targetNamespace="http://acasti.com/20241024" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:grce="http://acasti.com/20241024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="grce-20241024_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="grce-20241024_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://acasti.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>grce-20241024_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>grce-20241024_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.9.1.5252 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://acasti.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="grce-20241024.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://acasti.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: CoverAbstract to CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46535847055552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 24, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 24,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Grace Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001444192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1359336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">103 Carnegie Center<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">322-1602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GRCE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M^A;/552[QJ4%[I[&5'G@57G@M)>_AXS=O 8KD2SA8/T_(O0PFEZ/?J.8=K8
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ UD)<61PX9>H_ 0  / (   \
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M<F]P<R]A<' N>&UL4$L! A0#%     @ UD)<6<3RY,_N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ UD)<
M69E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " #60EQ93.,;PX\$  #8$0  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ UD)<
M69^@&_"Q @  X@P   T              ( !T@P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " #60EQ9EXJ[',     3 @  "P              @ &N#P
M7W)E;',O+G)E;'-02P$"% ,4    " #60EQ9'#AEZC\!   \ @  #P
M        @ &7$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ UD)<620>
MFZ*M    ^ $  !H              ( ! Q(  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ UD)<6660>9(9 0  SP,  !,
M     ( !Z!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&,A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20037633_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acasti.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20037633_8k.htm">ef20037633_8k.htm</File>
    <File>grce-20241024.xsd</File>
    <File>grce-20241024_lab.xml</File>
    <File>grce-20241024_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20037633_8k.htm": {
   "nsprefix": "grce",
   "nsuri": "http://acasti.com/20241024",
   "dts": {
    "inline": {
     "local": [
      "ef20037633_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "grce-20241024.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "grce-20241024_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "grce-20241024_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://acasti.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20241024to20241024",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20037633_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20241024to20241024",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20037633_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://acasti.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-24-044363-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-044363-xbrl.zip
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M?OXT]B9TBJ5E?'CWY+YB%1NSEQ46H$$2ZZIB?6NP&411(6%I">SCQ!6 \!*
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MUF+ ,V4Y!C\"YZK6E<10A4=Z6! UBP>Y]Y"4MG2)STF>]T(3\"XH ^O-)5Y
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M4(Z!D!+Q=41+8*WI*I@^GLI;B,YCF@W(17LKUG ;),I!+A8^1\^^P">*[/Z
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M+\9XN!UX=>Q)Y_!V27IT$^1TCY"MA-A%  -6-,5%4ZPNVXPU[Z.CJ_*8? -
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M=#&SQ66-L4L[CJNR7K>(WID@<&06?M1-,O56:8P2Y:+=N=@XYR83N.M$''*
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MOHE+VFYZS_Y1((N0787$C3MUI5W7[F-^?W+-SAE E:7 O'%\(!BCY(>,[)R
M.6/]Q%M.Z2NPBYQSAJDPWD."CX#=%*=G%+=Q_\"#EKTJ%HK(B;^H\3/NW+F>
M.M2ASBYHV2FF;?BZ,\>K=-Q4/+#*P.(98<(S/B=1\%K9+4 "+71"(EC%40R^
M:*BK=M"L^;C?HMEO)4]3VA;Z-TF\5RP -?X:>RFAZ"'S;F+-NTH[JE%2D9<4
MM]D[CS 1MTP30UPZ48(++!(*+B^@^S"6^F"5267W ;,8#^'(PX8CGSY^"$=^
M >OTGIBG;W]]??;77]^^>?OJ],/;=[_>+Y/TVS0/SHV# K R(-O><E4!R]M
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MK9;NAP/@ROB5;GN<=N%WW2_1\N*VH%MLE8',,Y@@Z[&S<=[LHBF0:3=6+$[
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M#R::\=+\T__Z\6L ->%?+KOEPO[E_P%02P,$%     @ UD)<64JHD3E- P
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MZ2:NX*;1FKY]DI4BUW\!4$L#!!0    ( -9"7%DIH VTN0@   A9   5
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M_W!@%Y$_Y!?T/_T/4$L! A0#%     @ UD)<69)?A]U3$P  O'H  !$
M         ( !     &5F,C P,S<V,S-?.&LN:'1M4$L! A0#%     @ UD)<
M60A&!$:Y!0  (QX  !0              ( !@A,  &5F,C P,S<V,S-?97@S
M+3$N:'1M4$L! A0#%     @ UD)<64:798VT7@  9PL" !0
M ( !;1D  &5F,C P,S<V,S-?97@S+3(N:'1M4$L! A0#%     @ UD)<64JH
MD3E- P  J0\  !$              ( !4W@  &=R8V4M,C R-#$P,C0N>'-D
M4$L! A0#%     @ UD)<62F@#;2Y"   "%D  !4              ( !SWL
M &=R8V4M,C R-#$P,C1?;&%B+GAM;%!+ 0(4 Q0    ( -9"7%F=45EO_ 4
M .M    5              "  ;N$  !G<F-E+3(P,C0Q,#(T7W!R92YX;6Q0
52P4&      8 !@"( 0  ZHH

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ef20037633_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="grce-20241024.xsd" xlink:type="simple"/>
    <context id="c20241024to20241024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001444192</identifier>
        </entity>
        <period>
            <startDate>2024-10-24</startDate>
            <endDate>2024-10-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20241024to20241024"
      id="Fact_e54af903f66e49ddabd66693de17fa37">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="c20241024to20241024"
      id="Fact_c71d4793dc7342339fd3fa30c2fb687b">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityRegistrantName
      contextRef="c20241024to20241024"
      id="Fact_06be0aa4f82b42f79a981e8decd9069e">Grace Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20241024to20241024"
      id="Fact_443d33fc2aec4028b1492a535ee27a37">0001444192</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20241024to20241024"
      id="Fact_dc309d8c63e74a46a1d2814207b8941e">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20241024to20241024"
      id="Fact_fd16dd88e4c54d3795d60d74abeb203f">2024-10-24</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20241024to20241024"
      id="Fact_cc76f6e46ff943ffaa0bef69a4184ff8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20241024to20241024"
      id="Fact_c549979620d840b88eb207f6e345ed6e">001-35776</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20241024to20241024"
      id="Fact_cfb2405198bb44ddb0f8850a92b1ecb1">98-1359336</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20241024to20241024"
      id="Fact_4732f0dfbbf840dfb1a06e732e0e966e">103 Carnegie Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20241024to20241024"
      id="Fact_484b7671eb834469b07b796f4a575e3d">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20241024to20241024"
      id="Fact_42656537c6b44218970fa4c3f4ad67c1">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20241024to20241024"
      id="Fact_12ee8f7f0dc14be38430a63fa0eabde1">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20241024to20241024"
      id="Fact_457b797bf9664a8e84c25f113f78d674">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20241024to20241024"
      id="Fact_56ca8b74b911418e883ecf163a2a15b4">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20241024to20241024"
      id="Fact_9d242bab3e8548bba5052217e93a7431">322-1602</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20241024to20241024"
      id="Fact_0f6fa2e3b9f14d9fa8e6b84430fa0554">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20241024to20241024"
      id="Fact_f1b0c3cb67744eed91c5ce32fd05b238">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20241024to20241024"
      id="Fact_5076829062264080b2d4c968f4a23f4d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20241024to20241024"
      id="Fact_c8b9822994054aaf803327c7ff2de257">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20241024to20241024"
      id="Fact_6dbff5feeb024a62a0dd280dcf623196">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20241024to20241024"
      id="Fact_4f604bbfcb1d41f69e00b3efc3178e66">GRCE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20241024to20241024"
      id="Fact_742438339723401c9acdd617e8e3451a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20241024to20241024"
      id="Fact_fe592cdac61f4a13aa3bba5b18c9f91a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
